ERβ alters the chemosensitivity of luminal breast cancer cells by regulating p53 function

Estrogen receptor α (ERα)-positive breast cancers tend to develop resistance to both endocrine therapy and chemotherapy. Despite recent progress in defining molecular pathways that confer endocrine resistance, the mechanisms that regulate chemotherapy response in luminal tumors remain largely elusiv...

Descripción completa

Detalles Bibliográficos
Autores principales: Bado, Igor, Pham, Eric, Soibam, Benjamin, Nikolos, Fotis, Gustafsson, Jan-Åke, Thomas, Christoforos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2018
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5976481/
https://www.ncbi.nlm.nih.gov/pubmed/29854295
http://dx.doi.org/10.18632/oncotarget.25147

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5976481/
https://www.ncbi.nlm.nih.gov/pubmed/29854295
http://dx.doi.org/10.18632/oncotarget.25147

Ejemplares similares